Inhibition of T24 human bladder carcinoma cell migration by RNA interference suppressing the expression of HD-PTP

Cancer Letters

Volumn 273, Issue 1, 2009, Pages 155-163

  Mariotti, Massimo ^a   Castiglioni, Sara ^a   Maier, Jeanette A M ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bladder cancer; Cell migration; FAK; HD PTP; Src

Indexed keywords

EPIDERMAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE HD PTP; STEROID RECEPTOR COACTIVATOR 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL MIGRATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RNA INTERFERENCE;

BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE 1; HUMANS; PROTEIN TYROSINE PHOSPHATASES, NON-RECEPTOR; RNA INTERFERENCE; RNA, SMALL INTERFERING; SRC-FAMILY KINASES; URINARY BLADDER NEOPLASMS;

EID: 56349161481     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.08.017     Document Type: Article

References (25)

1. Dube N., and Tremblay M.L. Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases from diabetes obesity to cell cycle and cancer. Biochim. Biophys. Acta 1754 (2005) 108-117
2. Stoker A.W. Protein tyrosine phosphatases and signalling. J. Endocrinol. 185 1 (2005) 19-33
3. Cohen L.A., and Guan J.L. Mechanisms of focal adhesion kinase regulation. Curr. Cancer Drug Targets 5 (2005) 629-643
4. Ishizawar R., and Parsons S.J. c-Src and cooperating partners in human cancer. Cancer Cell 6 (2004) 209-214
5. Summy J.M., and Gallick G.E. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 22 (2003) 337-358
6. Parsons S.J., and Parsons J.T. Src family, kinases key regulators of signal transduction. Oncogene 23 (2004) 7906-7909
7. Wilcox-Adelman S.A., Denhez F., and Goetinck P.F. Syndecan-4 modulates focal adhesion kinase phosphorylation. J. Biol. Chem. 277 36 (2002) 32970-32977
8. Mariotti M., Castiglioni S., and Maier J.A.M. Expression analysis and modulation by HIV-Tat of the tyrosine phosphatase HD-PTP. J. Cell. Biochem. 98 (2006) 301-308
9. M. Mariotti, S. Castiglioni, J.M. Garcia-Manteiga, L. Beguinot, J.A. Maier, HD-PTP inhibits endothelial migration through its interaction with Src, Int. J. Biochem. Cell Biol. (2008) [Epub ahead of print]. PMID: 18762272.
10. Chapman G., Liu L., Sahlgren C., Dahlqvist C., and Lendahl U. High levels of Notch signaling down-regulate numb and numblike. J. Cell Biol. 175 4 (2006) 535-540
11. Mariotti M., Castiglioni S., Beguinot L., and Maier J.A.M. The tyrosine phosphatase HD-PTP is regulated by FGF-2 through proteasome degradation. Front. Biosci. 11 (2006) 2138-2143
12. Cao L., Zhang L., Ruiz-Lozano P., Yang Q., Chien K.R., Graham R.M., and Zhou M. A novel putative protein-tyrosine phosphatase contains a BRO1-like domain and suppresses Ha-ras-mediated transformation. J. Biol. Chem. 273 (1998) 21077-21083
13. Toyooka S., Ouchida M., Jitsumori Y., Tsukuda K., Sakai A., Nakamura A., Shimizu N., and Shimizu K. HD-PTP: a novel protein tyrosine phosphatase gene on human chromosome 3p21.3. Biochem. Biophys. Res. Commun. 278 (2000) 671-678
14. Li M., Zhang Z.F., Reuter V.E., and Cordon-Cardo C. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder. Am. J. Pathol. 149 1 (1996) 229-235
15. Bernués M., Casadevall C., Caballín M.R., Miro R., Ejarque M.J., Chechile G., Gelabert A., and Egozcue J. Study of allelic losses on 3p, 6q, and 17p in human urothelial cancer. Cancer Genet. Cytogenet. 112 (1999) 42-45
16. Mariotti M., Castiglioni S., and Maier J.A.M. The tyrosine phosphatase HD-PTP: a novel player in endothelial migration. Biochem. Biophys. Res. Commun. 364 (2007) 534-539
17. Dominguez-Escrig J.L., Kelly J.D., Neal D.E., King S.M., and Davies B.R. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer. Clin. Cancer Res. 10 14 (2004) 4874-4884
18. Itoh M., Murata T., Suzuki T., Shindoh M., Nakajima K., Imai K., and Yoshida K. Requirement of STAT3 activation for maximal collagenase-1 (MMP-1) induction by epidermal growth factor and malignant characteristics in T24 bladder cancer cells. Oncogene 25 8 (2006) 1195-1204
19. Werdich X.Q., and Penn J.S. Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. Angiogenesis 8 (2005) 315-326
20. Schmidt M.H., Dikic I., and Bogler O. Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities. J. Biol. Chem. 280 (2005) 3414-3425
21. Guo W., and Giancotti F.G. Integrin signalling during tumour progression. Nat. Rev. Mol. Cell Biol. 5 (2004) 816-826
22. Angers-Loustau A., Cote J.F., and Tremblay M.L. Roles of protein tyrosine phosphatases in cell migration and adhesion. Biochem. Cell Biol. 77 (1999) 493-505
23. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 4 (2004) 470-480
24. Bjorge J.D., Jakymiw A., and Fujita D.J. Selected glimpses into the activation and function of Src kinase. Oncogene 19 (2000) 5620-5635
25. Schlaepfer D.D., Mitra S.K., and Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim. Biophys. Acta 1692 (2004) 77-102